Combined administration of (R)-Ketamine and the mGlu2/3 receptor antagonist LY341495 induces rapid and sustained effects in the CUMS model of depression via a TrkB/BDNF-dependent mechanism.
Authors: Anna Rafało-Ulińska, Piotr Brański, Agnieszka Pałucha-Poniewiera
Published in: Pharmaceuticals
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics
SJR best quartile: Q1